Purpose
Aortic stenosis is the most common type of valve disease in the developed world and, in an ageing population, represents an increasing healthcare burden.
The pathophysiology of calcific aortic stenosis appears to share many similarities with atherosclerosis, including lipid deposition, inflammation and calcification. Aortic valve calcification is mediated by many of the processes that drive skeletal bone formation and appears to be accelerated in patients with osteoporosis.
The aims of this study were to assess using PET-CT the relative contributions and interrelationships of calcification (18F-NaF) and inflammation (18F-FDG) in the aortic valve, regions of thoracic atherosclerosis and the skeletal bone of patients with calcific aortic stenosis.
Methods and Materials
We recruited patients from the out-patient clinic of the Royal Infirmary of Edinburgh, with a full spectrum of calcific aortic valve disease including those with aortic sclerosis.
Combined positron emission and computed tomography (PET CT) scans of the aortic valve, coronary arteries and aorta were performed with a hybrid scanner (Biograph mCT, Siemens Medical Systems, Erlangen, Germany).
PET-CT was performed using 18F-sodium fluoride (18F-NaF; calcification) and 18F-fluorodeoxyglucose (18F-FDG; inflammation) in 101 patients with calcific aortic valve disease (81 aortic stenosis, 20 aortic sclerosis). Tracer activity (tissue-to-background ratio; TBR) and calcium scores were measured in the aortic valve, coronary arteries and aorta.
Results
One hundred and one patients (72±8 years, 69% male) underwent PET imaging of their thorax 66±6 min after injection of 125±10 MBq of 18F-NaF and 94±7 Table 2 © -Edinburgh/UK 
Conclusion
Using PET/CT in patients with calcific aortic valve disease, we have compared calcification and inflammation in the aortic valve with regions of thoracic atheroma and skeletal bone. Whilst coexistent calcific atherosclerosis was observed in the vast majority of our patients, we have demonstrated important differences in the underlying pathophysiology of these two conditions. In particular, active calcification is more pronounced in stenotic aortic valves compared to regions of aortic atheroma, whereas the reverse is true of inflammation. Furthermore we have demonstrated that whilst markers of aortic valve calcification are poorly related to calcific activity in atheroma and bone, they have a strong relationship with the baseline aortic stenosis severity. We conclude that calcification is the predominant pathological process in aortic stenosis and that it is driven largely by local factors specific to the valve. Aortic stenosis is accompanied by calcific atherosclerosis in over 90% of patients yet it appears to have a distinct pathophysiology underlying its etiology and pathogenesis. In particular we have demonstrated that calcification is accelerated within the valve compared to atheroma and that in contrast to inflammation appears to be largely under the influence of local rather than systemic factors. 
